Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy [Phase 2]
Phase 2 clinical trial evaluating gemtuzumab ozogamicin in young patients with newly diagnosed acute myeloid leukemia undergoing remission-i…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating decitabine as maintenance therapy after standard treatment in adults with previously untreated acute myeloid leukem…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial in pediatric patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes evaluated a monoclonal…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute m…
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Clofarabine in Adult Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for clofarabine in adult patients with advanced solid tumors and various hematologic conditions; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: PRO#0118: Decitabine Plus Mini Flu-Bu [Phase 1]
A Phase 1 trial evaluating decitabine with a mini Flu-Bu conditioning regimen for acute myeloid leukemia and myelodysplastic syndrome has co…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A phase 1/2 trial evaluating the combination of clofarabine and cytarabine in children with refractory or relapsed acute myeloid leukemia or…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial update for elesclomol sodium in patients with relapsed or refractory acute myeloid leukemia, sponsored by Synta Pharm…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating CLAG plus Gleevec (imatinib) in relapsed or refractory acute myeloid leukemia has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Ondansetron Versus Aprepitant Plus Ondansetron for Emesis [Phase 2]
Phase 2 trial comparing ondansetron alone versus aprepitant plus ondansetron for prevention of emesis in patients with hematologic diseases,…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of arsenic trioxide, cytarabine, and idarubicin in patients with acute myeloid leukemia has compl…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial evaluating VNP40101M followed by cytarabine in older adults with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial of tipifarnib in older adults with acute myeloid leukemia has completed, with results posted in January 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial results evaluating the combination of oblimersen and gemtuzumab ozogamicin in older patients with relapsed acute myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 trial update on the combination of azacitidine and gemtuzumab ozogamicin in older patients with previously untreated acute myeloid l…
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 pediatric study evaluating a plerixafor-containing regimen as part of a second allogeneic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy [Phase 4]
A Phase 4 clinical trial update evaluating fludarabine and cytarabine chemotherapy for Acute Myeloid Leukemia with AML1-ETO fusion expressio…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS [Phase 3]
A Phase 3 randomized trial comparing Procrit (epoetin alfa) versus no Procrit in patients with acute myeloid leukemia and high-risk myelodys…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Timed-Sequential Induction in CBF-AML [Phase 3]
A Phase 3 clinical trial evaluating timed-sequential induction in core-binding factor acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/Phase 2 results for a Lestaurtinib–Cytarabine–Idarubicin regimen in younger patients with relapsed o…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial evaluating whether adding filgrastim and/or tretinoin to standard chemotherapy improves outcomes in patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial update evaluating a monoclonal antibody for treating acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 3]
Phase 3 trial comparing intensive versus nonintensive chemotherapy in older adults with acute myeloid leukemia or myelodysplastic syndromes.…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial evaluating the combination of 5-azacitidine and lenalidomide in myelodysplastic syndromes and acute myeloid leukemia was ter…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Intermittent Liposomal Amphotericin B Primary Prophylaxis [Phase 2]
An update on a Phase 2 trial evaluating intermittent liposomal amphotericin B as primary prophylaxis for fungal infections in Acute Myeloid …